ClinicalTrials.Veeva

Menu

AccuCath™ Intravenous (IV) Device Used by Vascular Access Team (VAT)

C

C. R. Bard

Status

Completed

Conditions

Vascular Access Complication

Treatments

Device: AccuCath Intravenous Catheter System

Study type

Interventional

Funder types

Industry

Identifiers

NCT01937195
VPW-STP-00002

Details and patient eligibility

About

The study will test a hypothesis that the AccuCath™ System will have a higher rate of successful first attempt peripheral intravenous (PIV) placement, higher completion of therapy, fewer complications, longer dwell times, and higher user satisfaction compared to Conventional IV Catheters.

Full description

Phase One is designed as a one-arm prospective study to compare patients using the AccuCath™ Intravenous Catheter System to the results found in literature. Phase Two is designed as a two-arm prospective randomized controlled study comparing the AccuCath™ Intravenous Catheter System to conventional PIV catheters. This study site will be completing Phase One only.

Enrollment

95 patients

Sex

All

Ages

18 to 89 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Male or female, age > or equal to 18 years or < or equal to 89 years old;
  2. Capable and willing to give informed consent;
  3. English speaking;
  4. Acceptable candidate for an elective, non-emergent PIV as determined by ordering physician;
  5. Admitted to study inpatient unit.

Exclusion criteria

  1. Male or female, < 18 years old or > 89 years old;
  2. Requirement for emergent IV placement (patient's condition would be compromised if there is a delay in IV placement);
  3. Previous venous grafts or surgery at the target vessel access site;
  4. Currently involved in other investigational clinical trials (unless permission is granted by other study PI);
  5. Females who are pregnant, planning to become pregnant within 3 months of the procedure, or lactating.

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

95 participants in 1 patient group

AccuCath Intravenous Catheter System
Experimental group
Description:
AccuCath Intravenous Catheter System will be used for IV therapy during inpatient stay. Intervention includes vascular access, fluid infusion, and blood sample removal.
Treatment:
Device: AccuCath Intravenous Catheter System

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems